ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1116

Comparing eGFR-Based vs. Kidney Failure Risk Equation-Based Strategies to Identify Veterans with Advanced CKD for Kidney Transplant Referral: A National VA Cohort Study

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Paulus, Amber B., Virginia Commonwealth University, Richmond, Virginia, United States
  • Gupta, Gaurav, Virginia Commonwealth University, Richmond, Virginia, United States
  • Shukla, Ashutosh M., University of Florida Health, Gainesville, Florida, United States
  • Silvey, Scott, Richmond VA Medical Center, Richmond, Virginia, United States
  • Patel, Nilang G., Richmond VA Medical Center, Richmond, Virginia, United States
Background

Transplant evaluation is typically recommended once eGFR falls below 20 mL/min/1.73m2 and US OPTN policy allows pre–emptive listing only below this threshold. 2–year Kidney Failure Risk Equation(KFRE) may offer an alternative strategy to identify high risk patients earlier & more accurately. We evaluated (1) characteristics of veterans meeting traditional eGFR ≤20 vs. KFRE ≥40% criteria, and (2) how these strategies differ in capturing patients who ultimately receive pre–emptive transplant referral, listing, or transplantation.

Methods

We created a national cohort of US veterans with advanced CKD using VA-CDW, VA Community Care Network,CMS & USRDS/UNOS data (2009–2023). Race–free CKD–EPI eGFR and 2–yr KFRE were calculated at all outpatient timepoints. Two non-mutually exclusive index cohorts were created: (1) first eGFR ≤20 and (2) first KFRE ≥40%. Exclusions approximated a transplant–eligible population as follows: prior ESRD/transplant, nursing home or frail status, home oxygen use, BMI >40, and non–skin cancer. Pre–emptive events were defined as those occurring before dialysis or death.

Results

22,309 of eGFR ≤20, and 12,823 of KFRE ≥40% were included in the final analysis. 43.2% of the eGFR ≤20 cohort also had KFRE ≥40%, Of those in KFRE ≥40% cohort, 71.0% had eGFR <20; while additional 29% with eGFR >20 were eligible for referral by KFRE criteria.

Compared with eGFR<20, veterans identified by KFRE≥40% were younger, had more albuminuria, higher comorbidity, and were more Hispanic/non-White. Nephrology engagement within 1 year was higher in the KFRE cohort than the eGFR cohort (64.8% vs. 57.2%; p<0.001) and was associated with higher referral.

Pre–emptive referral and waitlisting remained low but were higher in KFRE>40% than eGFR<20: referral 16.2% vs 12.8%, waitlisting 3.8% vs 2.7%, and transplant 0.7% vs 0.6%.

Earlier referral was associated with younger age, lower comorbidity burden, urban residence, higher income and higher education.

Conclusion

Among veterans with advanced CKD, eGFR ≤20 identified a larger, more heterogeneous population, whereas KFRE ≥40% identified a smaller group with higher predicted short-term kidney failure risk, including more minorities. Low referral, waitlisting, and transplantation rates highlight the need to explore a standardized VA workflow that converts high-risk status into timely referral.